Axovant Sciences Ltd. (AXON)
Feb 13 7:54pm Add AXON to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
AXON News Stream
All News Types
Commentary Corp. News Cramer Debt Offering Downgrade Earnings Hedge Fund IPOs Mgmt Change New Coverage (Bullish) Options Product News PT Lowered PT Raised Rating Reiterated (Bearish) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Resumes Coverage (Bullish) Stock Offering Upgrade
Loading, please wait...
View All AXON News
Axovant Sciences Ltd. (AXON) Company Bio
Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia, a condition characterized by significant decline in mental capacity and impaired daily function. The company was founded in 2014 and is based in Hamilton, Bermuda.
AXON Price/Volume Stats
Page generated in 0.7279 seconds.